Global Interventional Devices for Structural Heart Disease Market Growth 2023-2029

Global Interventional Devices for Structural Heart Disease Market Growth 2023-2029

The global Interventional Devices for Structural Heart Disease market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Interventional Devices for Structural Heart Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Interventional Devices for Structural Heart Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Interventional Devices for Structural Heart Disease is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Interventional Devices for Structural Heart Disease players cover Edwards Lifesciences, Boston Scientific Corporation, Medtronic, Abbott, Livanova, Cryolife, Braile Biomedica, Biomerics, LLC and NuMed Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Structural heart disease refers to physical and physiological changes in the heart caused by abnormalities in heart tissue or valves. Many structural heart diseases are congenital, and some structural heart disease develops later in life. There are three types of treatment for structural heart disease: drug therapy, transcatheter intervention, and open-heart surgery. Structural heart disease interventional devices are used in interventional therapy. Common interventional devices include congenital heart disease occluders, cardiogenic stroke occluders and heart valve products.

LPI (LP Information)' newest research report, the “Interventional Devices for Structural Heart Disease Industry Forecast” looks at past sales and reviews total world Interventional Devices for Structural Heart Disease sales in 2022, providing a comprehensive analysis by region and market sector of projected Interventional Devices for Structural Heart Disease sales for 2023 through 2029. With Interventional Devices for Structural Heart Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Devices for Structural Heart Disease industry.

This Insight Report provides a comprehensive analysis of the global Interventional Devices for Structural Heart Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Devices for Structural Heart Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Interventional Devices for Structural Heart Disease market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Devices for Structural Heart Disease and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Devices for Structural Heart Disease.

This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Devices for Structural Heart Disease market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Interventional Devices for Valvular Disease
Interventional Devices for Cardiogenic Stroke
Interventional Devices for Congenital Heart Disease

Segmentation by application
Congenital Heart Disease
Acquired Heart Disease

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences
Boston Scientific Corporation
Medtronic
Abbott
Livanova
Cryolife
Braile Biomedica
Biomerics, LLC
NuMed Inc.
AtriCure, Inc.
Comed B.V.
Shenzhen Salubris Pharmaceuticals Co., Ltd
LifeTech Scientific Corporation
Shanghai Push Medical Device Technology Co.,LTD
MicroPort Scientific Corporation
Scientech Medical
Starway Medical Technology Inc
Venus Medtech (Hangzhou) Inc.
APT Medical Inc
Shanghai HeartCare Medical Technology Co., Ltd
Peijia Medical Limited
Shanghai Hanyu Medical Technology Co., Ltd

Key Questions Addressed in this Report

What is the 10-year outlook for the global Interventional Devices for Structural Heart Disease market?

What factors are driving Interventional Devices for Structural Heart Disease market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Interventional Devices for Structural Heart Disease market opportunities vary by end market size?

How does Interventional Devices for Structural Heart Disease break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.